SecBot SecBot

MMED

MiniMed Group, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0002062583 Healthcare & Medical Devices
$18.65 +0.66 (+3.67%)
Nov 16 4:00 PM ET · prev $17.99
Market cap
$5.0B
Mid cap
Consensus
Buy
81% Buy or better · 21 analysts
Median target
$27.00
+45% · range $15.00–30.00
Next earnings
Nov 24
in 8 days
Since first trade
+0.9%
from $18.49 · Mar 6
30 days
+4.8%
from $17.79
Range since listing
$10.80–23.84
−22% from high · low May 15
Avg volume 20D
7.61M
shares / day
Short interest
9.81M
≈3.5% of shares · −52.8%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · since Mar 11
New fund stakes
4
Q3 2026 13F · 0 exits
SecBot read BULLISH 16 reports · 90 days
Balance 0 bearish · 3 bullish · 2 mixed · 11 neutral oldest → newest, height = score
Avg score ·High conf. 11/16 ·Next Earnings date, Nov 24, 2026

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Mar 11. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q3 2026: 29 added (4 new), 6 trimmed or exited. Largest new: Walleye Capital $27.2M, Hrt Financial $11.2M.

  • AnalystsBULLISH

    17 of 21 rate it Buy or better. Median target $27.00 (+45%).

  • Short sellersCOVERING

    Short interest −52.8% to 9.81M shares. 1.0 days to cover, ≈3.5% of shares.

  • TrendDOWNTREND

    4% below its 50-day average.

Who's buying

13F· Q3 2026
4
new positions
0
exits
$38.5M
in new stakes · top 2 shown
FundMoveSharesValue
FMR LLCDOUBLED3,406,771$66.3M
UBS Group AGDOUBLED2,736,650$53.3M
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUNDDOUBLED1,720,000$33.5M
Walleye Capital LLCNEW1,399,301$27.2M
FIRST TRUST ADVISORS LPDOUBLED822,845$16.0M
MORGAN STANLEYDOUBLED787,157$15.3M
STATE STREET CORPADD697,580$13.6M
HRT FINANCIAL LPNEW576,926$11.2M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

21 analysts
Buy 81% rate it Buy or better
Strong Buy6Buy11Hold4Sell0Strong Sell0
12-month targets · 15 analysts

Price is inside the target range. Median implies +45%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 13, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight
Oct 12, 2026Jefferies
INITIATE
INITIATEHold
Oct 8, 2026Mizuho
MAINTAIN
MAINTAINOutperform
Oct 7, 2026Barclays
INITIATE
INITIATEEqual-Weight
Sep 24, 2026Truist Securities
INITIATE
INITIATEBuy
Sep 3, 2026Morgan Stanley
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$0
open-market buys or sells · since Mar 11
DateInsiderTypeValue
Oct 28, 2026
Dianaty Ali
EVP Ch. Prod. & Tech Officer
Oct 28, 2026
TAX W/H$8.5K
Oct 15, 2026
Bricker Amy
Director
Oct 15, 2026
AWARD11,877 sh
Oct 15, 2026
Endicott David J.
Director
Oct 15, 2026
AWARD3,374 sh
Oct 15, 2026
Hopkins Robert (Bob)
Director
Oct 15, 2026
AWARD11,877 sh
Oct 15, 2026
Medtronic plc
10%+ Owner
Oct 15, 2026
OTHER252,813,348 sh
Oct 15, 2026
Chandrasena Gillian
SVP, Chief HR Officer
Oct 15, 2026
AWARD1,800 sh
Oct 15, 2026
Dianaty Ali
EVP Ch. Prod. & Tech Officer
Oct 15, 2026
AWARD11,108 sh
Oct 15, 2026
Lofton Kevin E
Director
Oct 15, 2026
AWARD836 sh

Earnings setup

Estimates
Nov 24
reports in 8 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

7 lobbying filings and 1 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
9,813,734
shares short
-52.8%
vs prior settlement
1.0
days to cover
≈3.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 Press
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 FDA
🔒 Fresh data, subscribers only
Nov 6, 2026 SEC
FMR LLC (Fidelity) filed a Schedule 13G disclosing a 13.5% passive stake in MiniMed Group as of October 30, 2026…
SC 13G · Impact 4/10
Oct 28, 2026 Insider
Dianaty Ali surrendered for taxes 449 shares
EVP Ch. Prod. & Tech Officer @ $18.93 ($8.5K)
Oct 22, 2026 SEC
Capital Ventures International, together with Susquehanna affiliates, disclosed a passive 7.8% stake in MiniMed Group…
SC 13G · Impact 4/10
Oct 15, 2026 Insider
Bricker Amy was granted 11,877 shares
Director
Oct 15, 2026 Insider
Endicott David J. was granted 3,374 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Nov 16, 2026
FDA
🔒 Fresh data, subscribers only
Nov 4, 2026
Earnings
MiniMed to Announce Its Fiscal Year 2027 Second Quarter Financial Results
NORTHRIDGE, Calif., Nov. 4, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it expects to…
Nov 3, 2026
Press release
MiniMed Appoints Dr. David Segal as Chief Medical Officer
NORTHRIDGE, Calif., Nov. 3, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the appointment of…
Oct 30, 2026
Short interest
Short Interest: MMED down 53% to 9.8M shares
Settlement 2026-10-30 | Days to cover: 1.00 | ≈3.49% of shares outstanding (est.)
Oct 5, 2026
Press release
Responding more frequently to MiniMed Smart MDI alerts linked to better glucose outcomes for people with diabetes
Six-month randomized trial found 8.1 percentage points more Time in Range and 0.6 percentage points lower HbA1c among higher responders. NORTHRIDGE…

SecBot reports

24 filings · 1 press release · 2 bullish · 0 bearish · 4 mixed · 18 neutral
All MMED filing & press-release reports (25)